Jinjun Bian
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Epidemiology top 5%
- Sepsis Diagnosis and Treatment
Papers in
- Immunology 16
- Inflammation biomarkers and pathways 5
- Immune Response and Inflammation 5
- Epidemiology 18
- Sepsis Diagnosis and Treatment 17
- Co-authors
- Xiaoming Deng (23 shared papers)Jiafeng Wang (16 shared papers)Xiaojian Wan (13 shared papers)Lulong Bo (22 shared papers)Keming Zhu (8 shared papers)Zhengyu Jiang (12 shared papers)Manli Yu (1 shared paper)Guang Yu (1 shared paper)
- Journals
- Aging (3 papers)Cellular and Molecular Life Sciences (3 papers)Computer Methods and Programs in Biomedicine (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)BMJ Open (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Jinjun Bian
70 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 202
- Epidemiology 467
- Immunology 229
- Developmental Neuroscience 37
- Critical Care and Intensive Care Medicine 47
Countries citing papers authored by Jinjun Bian
This map shows the geographic impact of Jinjun Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjun Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjun Bian more than expected).
Fields of papers citing papers by Jinjun Bian
This network shows the impact of papers produced by Jinjun Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjun Bian. The network helps show where Jinjun Bian may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinjun Bian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 308 | |
| 2 | 2011 | 127 | |
| 3 | 2019 | 108 | |
| 4 | 2014 | 104 | |
| 5 | 2016 | 93 | |
| 6 | 2010 | 84 | |
| 7 | 2024 | 82 | |
| 8 | 2016 | 72 | |
| 9 | 2018 | 68 | |
| 10 | 2021 | 56 | |
| 11 | 2020 | 53 | |
| 12 | Adenosine promotes Foxp3 expression in Treg cells in sepsis model by activating JNK/AP-1 pathway. | 2016 | 49 |
| 13 | 2017 | 37 | |
| 14 | 2020 | 36 | |
| 15 | 2020 | 35 | |
| 16 | 2020 | 35 | |
| 17 | 2022 | 30 | |
| 18 | 2022 | 30 | |
| 19 | 2023 | 29 | |
| 20 | 2022 | 28 |
About Jinjun Bian
Jinjun Bian is a scholar working on Immunology, Epidemiology, Anesthesiology and Pain Medicine, Oncology and Critical Care and Intensive Care Medicine, having authored 76 papers that have together received 1.9k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (17 papers), Anesthesia and Pain Management (6 papers), Inflammation biomarkers and pathways (5 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Immune Response and Inflammation (5 papers), Intensive Care Unit Cognitive Disorders (5 papers), Anesthesia and Sedative Agents (5 papers) and Acute Kidney Injury Research (4 papers). The work is most often cited by research in Cancer Research (202 citations), Epidemiology (467 citations), Immunology (229 citations), Developmental Neuroscience (37 citations) and Critical Care and Intensive Care Medicine (47 citations). Jinjun Bian has collaborated with scholars based in China and United States. Frequent co-authors include Xiaoming Deng, Jiafeng Wang, Xiaojian Wan, Lulong Bo, Keming Zhu, Zhengyu Jiang, Manli Yu, Guang Yu, Changli Wang and Yan Meng. Their work appears in journals such as Aging, Cellular and Molecular Life Sciences, Computer Methods and Programs in Biomedicine, Oxidative Medicine and Cellular Longevity and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.